Dimerix Limited (DIMERIX FPO [DXB]) aksje
DXB.AX
$0.1750-0.0100 (-5.41%)
Laster graf...
![DIMERIX FPO [DXB] logo](https://aktiespot.dk/stock-logos/DXB.AX-5199c057.webp){kind=small}
DIMERIX FPO [DXB]
Market Cap
$105,069,440
Åpning0.1850
Høy0.1870
Lav0.1750
Volum1.05M
P/EN/A
Markedsverdi105.07M
52-ukers høy0.6650
52-ukers lav0.1750
Gj.sn. volum1.98M
UtbytteN/A
Beta0.40
EPS-0.0300
Om Dimerix Limited (DIMERIX FPO [DXB]) aksje
Dimerix Limited, a biopharmaceutical company, develops and commercializes pharmaceutical products for unmet medical needs in Australia. It develops DMX-200 for the treatment of focal segmental glomerulosclerosis disease, diabetic kidney disease, and ARDS associated with COVID-19; and DMX-700 for orphan respiratory/renal disease, as well as proprietary Receptor-HIT assay technology. The company is headquartered in Fitzroy, Australia.
Selskapsinformasjon
Børs: ASX (ASX)
Sektor: Sundhed
Industri: Bioteknologi
Adresse:
425 Smith Street
3065 Fitzroy, Australia
3065 Fitzroy, Australia
Telefon: + 1300 813 321
Nettside: https://dimerix.com
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.
Laveste kursmål
1.89
↑ 982.9%
Gjennomsnittlig kursmål
1.89
↑ 982.9%
Median kursmål
1.89
↑ 982.9%
Høyeste kursmål
1.89
↑ 982.9%